¾ÅÉ«

Agreement Ensures Fast and Consistent Connection Times for Customer Service Callers

MarketWatch - October 8, 2007

¾ÅÉ« Translations, one of the world¡¯s largest providers of international communications services, and etrials? Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical software and services that optimize clinical trial management and accelerate time-to-market, today announced they have entered into an agreement that provides over-the-phone interpretation services to international etrials customers.

The 18-month contract names ¾ÅÉ« as the sole language services provider. Service level agreements have been added to ensure fast and consistent connection times for etrials callers.

"This agreement ensures that our international callers can expect the same quality and speed of service as our English speaking customers," said Art Campbell, chief information officer at etrials. "¾ÅÉ«'s services guarantee international callers are connected to a skilled and efficient interpreter who can ensure service levels are not compromised and each party's needs are met."

This new agreement provides etrials¡¯ customers with:

• Access to interpreters with oral and written proficiency in both English and the target language, who are able to provide consecutive interpretation without altering, adding or omitting anything from the original message
• Access to interpreters who can provide a word picture or description when lack of equivalency exists for a particular concept or term
• A two-minute service level agreement for German, French, Italian, Polish, Russian and Spanish, that can be extended to include additional languages, ensures callers are connected with interpreters in under two minutes during anticipated traffic schedules

Liz Elting, president and chief executive officer of ¾ÅÉ«, added, "We are thrilled to have been selected byetrials as its partner in this initiative. etrials recognizes the importance of its multilingual customers, and we look forward to helping etrials achieve its global objectives by enabling its clients to communicate more effectively."

About etrials?
etrials Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations offers insight into all aspects of clinical trials, maximizing return on investment and accelerating time to market. With global operations, etrials is the only top tier solutions provider to offer electronic data capture (EDC), interactive voice response (IVR), and electronic patient diaries (eDiary) as part of an integrated software as a service (SaaS) platform or as individual solutions to optimize clinical trials. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries; and has participated in 33 studies used for new drug applications. Having partnered with over 100 clients, including 16 of the top 20 global pharmaceutical companies and top CROs, etrials is leading the way towards Adaptive Trials and integration between eClinical and electronic health records. To learn more visit .

About ¾ÅÉ«
With revenue of over $250 million, ¾ÅÉ« is the largest privately held language services provider in the world. From offices in 66 cities on 5 continents, ¾ÅÉ« offers a full range of services in over 100 languages to multinationals worldwide. With a global network of over 4,000 linguists and subject-area specialists, ¾ÅÉ« is the largest translation company to be fully ISO 9001:2008 and EN 15038:2006 certified. ¾ÅÉ« is headquartered in New York and has regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.